Introduction
Urinary incontinence is a common issue in spayed female dogs, affecting more than 20% of them. It can lead to uncontrolled urine leakage, bladder infections, and skin irritation, making it a concern for both dogs and their owners.
Researchers at North Carolina State University College of Veterinary Medicine, with support from the AKC Canine Health Foundation, investigated regenerative medicine as a new treatment option. Their clinical trial tested whether injecting muscle stem cells could help dogs with urinary incontinence that didn’t respond to standard medications.
Key Points
- Regenerative medicine shows promise for treating urinary incontinence in female dogs.
- 14 out of 15 dogs improved after stem cell treatment.
- 11 dogs remained continent two years after the procedure.
- Few complications were reported during the clinical trial.
- Most dogs still needed oral medication, but at reduced levels.
Challenge Background
Urinary incontinence affects over 20% of spayed female dogs and is typically caused by weak urethral sphincter muscles. This leads to uncontrolled urine leakage, which can result in bladder infections and skin irritation. While oral medications are the standard treatment, they don’t work for every dog and can cause side effects or lose effectiveness over time. Alternative treatments like urethral injections or surgery have been explored but come with risks and inconsistent results.
The Breakthrough
With support from CHF, researchers at NC State tested a regenerative medicine approach using skeletal muscle stem cells (Grant 01844: Treatment of Urinary Incontinence with Multipotent Muscle Cells: A Regenerative Medicine Approach to a Common Canine Health Problem). They took a muscle biopsy from each dog’s triceps, processed the cells in a lab, and injected them into the tissue around the urethral sphincter. Dogs continued their oral medications for three months post-procedure, then stopped to assess the stem cell treatment’s effectiveness.
Results showed that 14 of 15 dogs became mostly or always continent, and 11 remained continent two years later. Although 13 dogs still needed some medication, the stem cell therapy significantly improved their condition. Urethral pressure measurements didn’t show major changes, but technical challenges and missed follow-ups may have affected results.
Impact & Next Steps
This study demonstrates that regenerative medicine could become a viable option for dogs with urinary incontinence, especially those not responding to traditional treatments. While not curative, the therapy offers long-term improvement with minimal complications. Future research may refine the technique, improve outcomes, and reduce reliance on medications. CHF continues to fund studies aimed at improving canine health and quality of life.
References:
1. Vaden, S. L., Mathews, K. G., Yoo, J., Williams, J. K., Harris, T., Secoura, P., Robertson, J., Gleason, K. L., Reynolds, H., & Piedrahita, J. (2022). The use of autologous skeletal muscle progenitor cells for adjunctive treatment of presumptive urethral sphincter mechanism incompetence in female dogs. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.16505
